Aflac Incorporated (AFL) : The highest short term price target forecast on Aflac Incorporated (AFL) is $77 and the lowest target price is $67. A total of 10 equity analysts are currently covering the company. The average price of all the analysts is $71.8 with a standard deviation of $3.88.
Aflac Incorporated (AFL) : 2 brokerage houses believe that Aflac Incorporated (AFL) is a Strong Buy at current levels. 9 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Aflac Incorporated (AFL). Zacks Investment Research suggests a Hold with a rank of 3. 1 analysts perceive the stock to be overvalued at the existing levels, hence their call is to Sell the stock.The median of all the 12 Wall Street Analysts endorse the stock as a Hold with a rating of 2.75.
Also, Brokerage firm SunTrust Robinson Humphrey maintains its rating on Aflac Incorporated (NYSE:AFL). As per the latest information, the brokerage house raises the price target to $75 per share from a prior target of $69. The shares have been rated Neutral. The rating by the firm was issued on August 1, 2016.
Aflac Incorporated (NYSE:AFL): The stock opened at $74.28 on Thursday but the bulls could not build on the opening and the stock topped out at $74.36 for the day. The stock traded down to $73.37 during the day, due to lack of any buying support eventually closed down at $73.87 with a loss of -0.42% for the day. The stock had closed at $74.18 on the previous day. The total traded volume was 1,415,585 shares.
Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflacs insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental and vision care plans, and loss-of-income products.